SLC2A5 and leukemia: Additionally, Tilekar et al. (2020), identified a thiazolidinedione derivative, G5, as a potent GLUT5 inhibitor, exhibiting anti-proliferative actions and promoting cell cycle arrest in leukemia cells, leading to apoptotic and necrotic cell death (Fig. 3).